Yahoo Finance

Truist lowered the firm’s price target on Cross Country Healthcare (CCRN) to $15 from $17 and keeps a Hold rating on the shares as part of a broader research note on Healthcare Staffing names. Conversations with private staffing firms indicate that while Travel Nursing demand is showing signs of a bottom, nothing definitive yet signals that the trough has been reached, the analyst tells investors in a research note. Truist further cites industry sources state that the industry remains oversupplied with recruiter capacity, which has continued to put downwards pressure on gross margins, while hospitals remain focused on reducing temp labor expense, which is pushing orders at bill rates insufficient to draw supply off the sidelines.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on CCRN:

• Cross Country Healthcare to Announce Q3 2024 Earnings

• Curbline Properties to replace Cross Country Healthcare in S&P 600 at open 10/1

• Cross Country Healthcare Issues Non-Binding Press Release